Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month - Business News Week
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal’s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cyclophosphamide shortages and supply chain risks, safeguarding access to this critical medicine for patients across […] The post Piramal Pharma Solution…
ADKhabar
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cycl...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
